TRANSCRIPT

Q2 2024 — Fixed income management remarks

Q2 2024PDF · 22 pages236 KB
Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	1
Barclays PLC H1 2024 Results
Fixed Income Conference Call Speech
Anna Cross, Group Finance Director
Daniel Fairclough, Group Treasurer
Title slide: Barclays PLC Fixed Income Investor Call – H1 2024 Results
Announcement
1. Good afternoon, everyone and welcome to the fixed income
investor call for our half year 2024 results and investor update. I’m
joined today by Dan Fairclough, our Group Treasurer.
2. Let me begin with a brief overview of our performance over the first
half of the year and then I’ll hand over to Dan for his review of the
balance sheet.
Slide 3: We set out financial targets and are on the path to delivery
3. As Venkat and I stated this morning, we set out a three-year plan
in February to deliver a better run, more strongly performing and
higher returning Barclays.
4. We are continuing to execute in a disciplined way against the plan.
Investor Relations	Investor Relations

-- 1 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	2
5. Our second quarter and first half performance keeps pace with our
2024 and 2026 financial targets, which are:
6. First, grow returns, with a target RoTE of above 12% in 2026.
7. Second, distribute more capital to shareholders, with a target of
returning at least £10 billion between 2024 and 2026.
8. And third, rebalance the bank, with a target to reduce RWAs in the
Investment Bank from 58% of Group RWAs at the end of 2023 to
around 50% in 2026.
9. Return on Tangible Equity was 9.9% in the second quarter, and
11.1% in the first half of the year, on track for our target of above 10%
in 2024.
10. 	Total income for Q2 was £6.3 billion and £13.3 billion for the
first half.
11. 	We remain focused on the quality and stability of our income
mix and we increased our 2024 Net Interest Income guidance.
12. 	We continue to control our costs well and are seeing the
benefit of the cost actions we took in the fourth quarter of last year.
13. 	Our cost to income ratio was 63% in the second quarter and
62% in the first half.

-- 2 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	3
14. 	We remain well-capitalised. Our CET1 ratio was 13.6%,
comfortably within our 13 to 14% target range and Dan will cover this
in more detail shortly.
15. 	We continue to manage our credit carefully. Impairment
charges have improved in the US Consumer Bank, in line with our
expectations, with overall credit performance strong, particularly in the
UK.
16. 	I’ll spend a moment on loan provisioning on the next slide.
Slide 4: LLR of 38bps; maintaining through the cycle guidance of 50-
60bps
17. 	The impairment charge of £384 million in Q2 equated to a Loan
Loss Rate of 38 basis points, below our through the cycle guidance of
50 to 60.
18. 	The Barclays UK charge was just £8 million, a Loan Loss Rate of 1
basis point, which reflected continued benign credit conditions and an
£18 million release of economic uncertainty PMAs.
19. 	Our UK customers continue to act prudently, with little current sign
of stress, evidenced by continued low and stable delinquencies.

-- 3 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	4
20. 	Starting from this low base, we expect the Barclays UK loan loss
rate to track towards circa 35 basis points over time, as we complete
the Tesco Bank acquisition and grow the balance sheet, as outlined in
our Investor Update.
21. 	In the US Consumer Bank, the Q2 charge increased year on year
to £309 million and Loan Loss Rate to 438 basis points.
22. 	We still expect the US Consumer Bank impairment charge to
improve in the second half compared to the first, resulting in a lower
full year charge in 2024 versus 2023.
23. 	And we continue to guide to a Loan Loss Rate trending towards
the long-term average of circa 400 basis points.
24. 	In summary, we remain focused on disciplined execution.
25. 	This is the second quarter of progress against the targets we laid
out in February, which we are reiterating today, and we remain on
track.
26. 	I’ll now hand over to Dan for the balance sheet highlights.

-- 4 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	5
Slide 6: H1 24 highlights
27. 	Thanks Anna.
28. 	Our balance sheet continues to be strong, as evidenced by
the metrics on the slide.
29. 	The CET1 ratio of 13.6% places us firmly within our target
range and the MREL ratio of 33.5% provides £12bn of headroom
above our requirements. A liquidity coverage ratio of 167% and low
loan to deposit ratio of 72% demonstrates our robust liquidity position.
30. 	Let me begin with capital on slide 7.
Slide 7: CET1 ratio within the 13-14% target range
31. 	We ended the first half of the year with a CET1 ratio of
13.6%.
32. 	We accreted c.80bps of capital from profits over the first six
months, demonstrating our organic capital generation capability and
supporting shareholder returns and RWA growth.
33. 	As a reminder, we have recently announced two inorganic
transactions that will impact capital – namely c.30bps of capital
consumption when the Tesco acquisition completes in Q4 and the
c.10bps accretion from the sale of the German consumer business

-- 5 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	6
expected to complete either later this year or early next. The sale of
our Italian mortgage business had no material capital impact.
34. 	Further out, we have the expected regulatory items that we
have previously called out – Basel 3.1 and the US consumer bank
IRB impacts.
35. 	Our guidance remains that the aggregate impact on RWAs to
be at the lower end of 5-10%. Clearly on Basel 3.1 there is a higher
level of uncertainty internationally and we await the further set of PRA
rules on credit risk and other items.
36. 	As Anna mentioned this morning, we now expect the IRB go
live for US cards to be in Q1 2025, reflecting a refined approval and
implementation timetable.
37. 	All the items that I’ve mentioned were part of the plan that we
announced in February and, to remind you, our 2024 RoTE guidance
of 10% translates to c.150bps of CET1 ratio accretion.
38. 	As we set out in February, having a robust capital position is
the primary objective of our capital management framework and we
are comfortable with our capital ratio and target range.

-- 6 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	7
Slide 8: Operating with a prudent buffer to each tier of capital
requirements
39. 	Moving up the capital stack, on slide 8, we show our total
capital requirements as a proportion of RWAs, split out by Tier 1 and
total capital respectively.
40. 	We continue to target a prudent buffer against each of these
requirements.
41. 	Taking each tier in turn.
42. 	Our Tier 1 ratio is 17.3% with a healthy headroom over our
14.4% regulatory requirement, for reasons I have outlined before.
43. 	Within this ratio, you can see that we had a robust AT1
component of 3.7% or 3.3% when reflecting the call announcement of
this morning.
44. 	We have exercised all of our AT1 calls due in 2024, which
totals £2.8bn equivalent, and issued £1.25bn in a Sterling AT1 in May.
45. 	This is consistent with our guidance at the beginning of the
year to be a net negative issuer in 2024.

-- 7 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	8
46. 	Given the prudent position that we run, we do not currently
expect to issue any further AT1 this year and we will be a broadly
balanced AT1 issuer going forward across the portfolio.
47. 	Let me spend a brief moment on the 6-month par call feature
which is common across the AT1 market.
48. 	This feature has been included in all Barclays’ AT1 securities
issued since 2020.
49. 	We see it as constructive, providing us genuine flexibility
within the six-month window as we continue to manage AT1 calls on a
portfolio basis.
50. 	Our approach to assessing AT1 calls also remains as before,
and this feature will be considered within our longstanding economic
call framework.
51. 	We remain mindful that views on the feature are evolving,
including its use and inclusion for future issuance.
52. 	Our first call decision on such a security is not until
December 2025 at the earliest and all calls will continue to remain
subject to market conditions and regulatory permission at the relevant
time.

-- 8 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	9
53. 	Moving onto total capital, our buffer over our regulatory
minimum remains healthy at 240bps.
54. 	This was supported by our successful 1.5bn Euro 12NC7
Tier 2 issuance in May.
55. 	The strength of our Tier 1 level also contributes to this total
capital position.
56. 	As a result, our Tier 2 requirements continue to remain
relatively modest, largely replacing our existing call and amortisation
profile.
Slide 9: MREL position well established; 80% of 2024 issuance plan
complete
57. 	Turning now to slide 9, in addition to our AT1 and Tier 2
transactions I have mentioned, we have also executed £7.2bn of
Senior from our holding company.
58. 	These all contribute to meeting our MREL requirements and
we have issued £10bn in MREL eligible instruments year to date.
59. 	We stated at the beginning of the year that our MREL funding
plan for 2024 would be around £12bn and this remains our intention.

-- 9 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	10
60. 	For the circa £2bn remaining, which does not include AT1,
we continue to monitor market opportunities across all currencies.
61. 	At the operating company, BUK issued £500m Sterling
covered bonds, demonstrating external market access from the entity
at a competitive pricing level.
62. 	This was quite rare for us and generally public funding
requirements for our operating companies will be limited going
forward.
Slide 10: Diverse and stable franchise deposit base
63. 	Moving onto deposits on slide 10.
64. 	Our stable deposit base continues to reflect the diverse
deposit franchise that we have across consumer, SME and corporate
sectors.
65. 	Deposits have grown modestly across all the segments, and
partially offset by a temporary decline in short term deposits from
banks.
66. 	Given continued quantitative tapering and upcoming TFSME
repayments, the outlook for overall money supply remains muted, and

-- 10 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	11
we expect this to be reflected in a broadly stable deposit base over
the year.
67. 	And to remind you that we expect £7bn of deposits from the
Tesco consumer portfolios to transfer in Q4 this year.
Slide 11: Prudently managed LCR supported by a highly liquid balance
sheet
68. 	Onto the next slide on liquidity.
69. 	Our average LCR at 167% provided £123bn in excess of the
regulatory requirement and our liquidity position is robust.
70. 	This liquidity position also provides ample coverage for our
TFSME drawings of £18bn, and we have applied for £4bn of TFSME
lending to be extended to 2031 under the terms of the BoE’s recent
extension announcement.
71. 	Whilst we note that the BoE’s continuing actions to reduce its
holdings of gilts are likely to restrict growth in UK money supply, we
welcome their commitment to ensure stable reserves in the system.
Slide 12: Predictable uplift from the structural hedge
72. 	Moving onto the structural hedge on slide 12.

-- 11 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	12
73. 	As a reminder, the structural hedge is designed to reduce
volatility in NII and manage interest rate risk.
74. 	In a falling rate environment, the hedge would help to offset
some of the downward pressure to NII.
75. 	The base building blocks of our structural hedge remain the
same as we outlined in February. We have around £170 billion of
hedges maturing between ‘24 and ‘26 and we expect to roll the
majority of these onto higher swap rates.
76. 	In response to greater stability in customer and client deposit
behaviour, we have slightly increased the average duration.
77. 	The expected NII tailwind is significant and predictable. £11.7
billion of aggregate gross income is now locked in over the 3 years to
the end of 2026, up from £9.3 billion at Q1, reflecting both an
additional quarter of rolling and also the modest adjustment to
duration.
78. 	As we said in February, reinvesting around three quarters of
the £170 billion at around 3.5% would compound over the next 3
years, to increase structural hedge income in 2026 by circa £2 billion
versus 2023.

-- 12 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	13
79. 	The stabilising effect of our structural hedge helps to dampen
our NII sensitivity to interest rates, which we disclose on the next
slide.
Slide 13: Lower interest rate sensitivity, with one rate cut expected in
2024
80. 	Slide 13 shows an illustrative and simplistic sensitivity to
interest rate moves for our customer banking book, including hedges.
It assumes a static balance sheet and a parallel shift of 25bps to base
and swap rates.
81. 	Given the high proportion of balances and the programmatic
approach we take with our structural hedge, we have a sensitivity to
marginal rate changes that we believe is lower than many UK peers.
82. 	We have updated some of our macro-economic assumptions
in Q2, including the UK base rate at 5% at the end of this year, which
is 100bps higher than our expectation in February.
83. 	Alongside the product dynamics that Anna mentioned this
morning, this was a driver in our upgrade in our 2024 NII guidance.

-- 13 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	14
84. 	A further UK rate cut to 4.75% towards the end of the year,
which is currently assumed in the latest consensus, would not
materially change NII this year.
Slide 14: Targeting Barclays PLC to be “A” composite across all indices
over time
85. 	Turning to credit ratings on slide 14.
86. 	Our medium-term aim for Barclays PLC senior to qualify as
single A composite across all indices remains an important medium-
term target.
87. 	We continue to engage with the credit rating agencies in a
focussed and constructive manner, as they follow our execution of our
three-year plan.
Slide 15: Risk transfer transactions enhance Barclays’ risk management
capabilities
88. 	Before I conclude, let me now turn to slide 15 and to the topic
of risk transfer trades which I know has gained the interest of both the
sellside and buyside since the start of this year.

-- 14 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	15
89. 	It has been another active year for us in this space, and
we’ve executed eight transactions backed by over £6.4bn of
exposures, primarily re-financings, to hedge our corporate loan book.
90. 	We also completed a sale of $1.1bn of receivables from our
US credit card portfolio to Blackstone, also providing risk transfer.
91. 	At the heart of what we aim to achieve across these
programmes is to enhance our risk management capabilities.
92. 	We transfer credit risk to investors, typically asset managers
and pension funds.
93. 	We benefit from relief in stress when defaults on single
names have occurred over the years, and also theoretically in
regulatory stress tests.
94. 	The resulting reduced risk weight density also means that
these transfers reduce capital requirements, subject of course to
regulatory oversight, noting the importance of passing strict tests to
demonstrate ongoing significant risk transfer.
95. 	Therefore, in addition to the risk decision, we also weigh up
the cost of the protection against the capital that gets released, and a
consideration for the go-ahead of these trades is ensuring overall
RoTE accretion.

-- 15 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	16
96. 	We have risk transfer programmes of different types across a
number of our loan portfolios, including corporate loans, mortgages
and credit cards.
97. 	I have split them by synthetic versus cash structures and will
explain briefly the difference.
98. 	In Synthetic SRT deals the underlying loans remain on our
balance sheet for accounting purposes. Our synthetic SRTs involve
issuing notes to investors, the repayment of which is linked to the
underlying assets (or credit linked notes), so we take no counterparty
credit risk.
99. 	In cash SRT deals the risk and rewards of the underlying
loans are passed to the investor to such an extent that the assets are
derecognised from our balance sheet, however we retain the legal
title, and we receive income from the resulting arrangement in
servicing fees.
100. 	To date the synthetic SRT transactions have been backed by
corporate exposures and the cash SRT transactions by more granular
retail exposures. Our experience in both allows us to select the
optimal structure for any future transactions.
101. 	Turning to slide 16.

-- 16 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	17
Slide 16: Risk transfer activities focused on corporate loans and credit
cards
102. 	Our corporate loan book across the IB and UK Corporate
Bank has used the Colonnade programme since 2016.
103. 	Today, we benefit from £54bn of notional protection on
corporate loans and RCFs – to be clear, this is across on and off-
balance sheet exposures.
104. 	It’s worth noting that we also have other risk management
tools, and we supplement SRT with other forms of market hedging.
105. 	We are often asked two questions by the market about this
programme, namely refinancing risk and counterparty risk.
106. 	In terms of managing our refinancing, our maturity profile is
actively managed, and we have had no more than £2bn of RWAs
requiring refinancing in any quarter.
107. 	It’s also worth stating that we view the colonnade programme
is at maturity from both a volume and hedge proportion perspective.

-- 17 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	18
108. 	Lastly, the SRT market is active and deep, with issuance last
year of £180bn according to the IAPCM securitisation survey and we
have issued £6.4bn so far this year.
109. 	On the latter question, the programme is fully funded and, as
such, there is no counterparty risk like any other form of bond
issuance.
110. 	Turning to the right-hand side of the slide.
111. 	We were pleased to initiate risk transfers for the US credit
card book consistent with our stated intention at the beginning of the
year.
112. 	This particular securitisation involved selling the risk of
$1.1bn of receivables to Blackstone and we receive servicing fees.
113. 	We continue to see significant opportunities for these trades
on a selective basis as part of the broader strategy of the US
Consumer Bank business.
114. 	I hope this was a helpful introduction on the ways we conduct
risk transfers at Barclays.
115. 	In short, the enhanced risk capabilities from these trades can
provide us with an important risk management tool and returns
accretive options.

-- 18 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	19
Slide 17: Daniel Fairclough
116. 	Let me conclude on the half year results overall.
117. 	Our robust capital and liquidity positions are important
foundations for the strategy and targets that we set out in our three-
year plan in February.
118. 	The performance of our balance sheet in the first half of this
year has been consistent in supporting the strategic aims of the
group.
119. 	And with that, I’ll hand back to Anna.

-- 19 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	20
Important Notice
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. The information, statements and
opinions contained in this presentation do not constitute a public offer under any applicable legislation, an offer to sell or
solicitation of any offer to buy any securities or financial instruments, or any advice or recommendation with respect to
such securities or other financial instruments.
Information relating to:
• 	regulatory capital, leverage, liquidity and resolution is based on Barclays' interpretation of applicable rules
and regulations as in force and implemented in the UK as at the reporting date, including, but not limited to:
the UK implementation of the Capital Requirements Directive; CRR; and any applicable delegated acts,
implementing acts or technical standards and as such rules and regulations form part of domestic law by
virtue of the European Union (Withdrawal) Act 2018, in each case as amended. All such regulatory
requirements are subject to change and disclosures made by the Group will be subject to any resulting
changes. The Pillar 2A is also subject to at least annual review;
• 	MREL is based on Barclays' understanding of the Bank of England's policy statement on "The Bank of
England's approach to setting a minimum requirement for own funds and eligible liabilities (MREL)"
published in December 2021, updating the Bank of England's June 2018 policy statement, and its MREL
requirements communicated to Barclays by the Bank of England. Binding future MREL requirements
remain subject to change, as determined by the Bank of England, taking into account a number of factors
as described in the policy, along with international developments;
• 	future regulatory capital, leverage, liquidity, funding and/or MREL, including forward-looking illustrations,
are provided for illustrative purposes only and are not forecasts of Barclays’ results of operations or capital
position or otherwise. Illustrations regarding the capital `flight path, end-state capital evolution and
expectations and MREL build are based on certain assumptions applicable at the date of publication only
which cannot be assured and are subject to change.
Non-IFRS performance measures
Barclays’ management believes that the non-IFRS performance measures included in this presentation provide valuable
information to the readers of the financial statements as they enable the reader to identify a more consistent basis for
comparing the businesses’ performance between financial periods and provide more detail concerning the elements of
performance which the managers of these businesses are most directly able to influence or are relevant for an assessment
of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is
monitored by Barclays’ management. However, any non-IFRS performance measures in this presentation are not a

-- 20 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	21
substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix of the
Barclays PLC Results Announcement for the period ended 30 June 2024, Barclays PLC’s Current Report on Form 6-K
filed with the U.S. Securities and Exchange Commission on 1 August 2024, and the Group Reporting Changes 2023
Results Resegmentation Document, respectively, which are available at Barclays.com, for further information and
calculations of non-IFRS performance measures included throughout this presentation, and the most directly comparable
IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities
Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the
Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual
results or other financial condition or performance measures could differ materially from those contained in the forward-
looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or
current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’,
‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning.
Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of
the Group (including during management presentations) in connection with this document. Examples of forward-looking
statements include, among others, statements or guidance regarding or relating to the Group’s future financial position,
business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other
regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity,
projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including
environmental, social and governance (ESG) commitments and targets), plans and objectives for future operations and
other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and
uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date
on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation:
changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of
practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard
to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current
and future legal proceedings and regulatory investigations; the Group’s ability along with governments and other
stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and
geopolitical risks and incidents, pandemics and similar events beyond the Group’s control; the impact of competition in the
banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable
to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including
inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign
exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit

-- 21 of 22 --

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
(Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. 	22
ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer
behaviour; the direct and indirect consequences of the conflicts in Ukraine and the Middle East on European and global
macroeconomic conditions, political stability and financial markets; political elections including the impact of the UK,
European and US elections in 2024; developments in the UK’s relationship with the European Union (EU); the risk of
cyberattacks, information or security breaches, technology failures or other operational disruptions and any subsequent
impacts on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of
acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group’s control. As a
result, the Group’s actual financial position, results, financial and non-financial metrics or performance measures or its
ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s
forward-looking statements. In setting its targets and outlook for the period 2024-2026, Barclays has made certain
assumptions about the macro-economic environment, including, without limitation, inflation, interest and unemployment
rates, the different markets and competitive conditions in which Barclays operates, and its ability to grow certain
businesses and achieve costs savings and other structural actions. Additional risks and factors which may impact the
Group’s future financial condition and performance are identified in Barclays PLC’s filings with the US Securities and
Exchange Commission (“SEC”) (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial
year ended 31 December 2023), which are available on the SEC’s website at www.sec.gov.
Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction, (including,
without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to
update publicly or revise any forward-looking statements, whether as a result of new information, future events or
otherwise.

-- 22 of 22 --